Your Dedicated Research Partner
Mission Statement
“Providing our community with diverse treatment options through trusted research.”
Company Summary
Originally founded in 2006, TrueBlue Clinical Research, formally MOORE Clinical Research, specializes in conducting multi-specialty Phase II-IV clinical trials. We have 3 clinical research facility locations in the Tampa Bay area, each clinical research facility covering a large and diverse patient base over 2 counties.
Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity and reliability. Our demonstrated track record since our inception in 2006, puts TrueBlue Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.
Services & Capabilities
- Multi-specialty Phase II – IV Clinical Trials
- More than 500 clinical trials completed collectively
- Database of 300,000 searchable patients
- Consistent recruitment rate of 94%
- Consistent retention rates of over 90%
- 1-3 day turnaround for EDC entry & query resolution
- 3 newly expanded and updated clinics located in the Tampa Bay Metro area
- Access to Tampa Bay population of over 3 million
- Virtual trial and remote monitoring capabilities
- CTMS, e-Regulatory & e-Source systems in use for all studies
- Rescue site experience and capabilities
- Full time, bilingual clinical and recruitment teams
- GCP, CPR, ACLS and IATA trained staff
- PPM-CLIA licensure
- Experience with most EDC, IWRS/IVRS systems
- Private monitoring space with WiFi access
- Secure, climate controlled ambient and refrigerated drug storage with digital WiFi temperature monitoring, excursion notification and back up generator
- Centrifuges, minus 20 & minus 80 freezers for clinical laboratory specimen collection & handling
- Laminar Flow Hood for drug preparation and safety
- Safety equipment includes crash cart, emergency meds, oxygen and defibrillators
THERAPEUTIC AREAS
- Internal Medicine
- Infectious Disease
- Mental Health
- Dermatology
- Immunology
- Allergy/Asthma
- Vaccine
- Neurology
- Devices
Clinical Investigators & Certified Coordinators
- Michael Tharp, MD – Board Certified Dermatology and Internal Medicine,
Academy of Physicians in Clinical Research – 40+ years of clinical experience.
- Amy Ross, MD – Board Certified Dermatology and Micrographic Dermatologic Surgery, Academy of Physicians in Clinical Research – 25+ years of clinical experience.
- Scott Miller, MD – Board Certified Internal Medicine and Cardiovascular Disease,
Academy of Physicians in Clinical Research – 25+ years of clinical experience.
- Julian Melamed, MD – Board Certified Internal Medicine and Allergy and Clinical
Immunology, Academy of Physicians in Clinical Research – 35+ years of clinical experience.
- George Monlux, MD – Board Certified Family Practice Medicine,
Academy of Physicians in Clinical Research – 25+ years of clinical experience
- Katherine Bencze, MD – Board Certified Neurology,
30+ years of clinical experience.
- Bryan Julian, RN, Director of Clinical Operations
- Theresa Lopez, CCMA, CCRP, Quality & Compliance Manager
- Sergio Aguilar, Clinical Research Coordinator
- Xairyl Ruiz, Clinical Research Coordinator
- Rosemarie Acuna, LPN, Clinical Research Nurse/Team Lead
Clinical Trial Recruitment
Each study begins with a specialized process by our recruitment team to identify and match potential patients, from our extensive database and from the surrounding communities, to your specific study needs and qualifications. Experienced on-call recruitment team utilized for nights and weekends outside of normal business hours, so a call or inquiry will never be missed.
- Dedicated, on site recruitment center
- Bilingual recruitment team
- Recruitment Rate of 94%
- Constant contact with database of patients via phone, text, email and social media
TrueBlue Clinical Research consistently delivers positive results over a variety of indications.
ACNE VULGARIS STUDY
Actual Enrollment: 96
Enrollment Rate: 100%
Retention Rate: 93%
Enrollment Timeline: 3 weeks
ACNE VULGARIS STUDY
Enrollment Goal: 570
Actual Enrollment: 574
Enrollment Rate: 101%
Retention Rate: 90%
Enrollment Timeline: 12 weeks
ACTINIC KERATOSIS STUDY
Actual Enrollment: 31
Enrollment Rate: 155%
Retention Rate: 97%
Enrollment Timeline: 12 weeks
GLUCOSE MONITOR DEVICE STUDY
Actual Enrollment: 207
Enrollment Rate: 100%
Retention Rate: 100%
Enrollment Timeline: 12 weeks
TINEA PEDIS STUDY
Actual Enrollment: 31
Enrollment Rate: 124%
Retention Rate: 97%
Enrollment Timeline: 10 weeks
PLAQUE PSORIASIS STUDY
Enrollment Goal: 3
Actual Enrollment: 9
Enrollment Rate: 300%
Retention Rate: 100%
Enrollment Timeline: 2 weeks
For more information on partnering with TrueBlue Clinical Research, please contact:
